Valproic acid

Generic Name
Valproic acid
Brand Names
Depakene, Depakote, Epival
Drug Type
Small Molecule
Chemical Formula
C8H16O2
CAS Number
99-66-1
Unique Ingredient Identifier
614OI1Z5WI
Background

Valproic acid, or valproate, is an fatty acid derivative and anticonvulsant originally synthesized in 1881 by Beverly S. Burton. It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century. In 1963, a serendipitous discovery was made by George Carraz during his investigations into the anticonvulsant effects o...

Indication

Indicated for:

1) Use as monotherapy or adjunctive therapy in the management of complex partial seizures and simple or complex absence seizures.

2) Adjunctive therapy in the management of multiple seizure types that include absence seizures.

3) Prophylaxis of migraine headaches.

4) Acute management of mania associated with bipolar disorder.
...

Associated Conditions
Bipolar Disorder (BD), Complex Partial Seizure Disorder, Depressive Episodes, Migraine, Petit Mal Epilepsy, Seizure, multiple types, Acute Manic episode
Associated Therapies
-

Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania

Phase 2
Completed
Conditions
First Posted Date
2005-09-21
Last Posted Date
2010-11-25
Lead Sponsor
Beth Israel Medical Center
Target Recruit Count
36
Registration Number
NCT00206778
Locations
🇺🇸

Beth Israel Medical Center, New York, New York, United States

Study of Depakote for Behavioral and Psychological Symptoms in Dementia

Phase 1
Conditions
First Posted Date
2005-09-20
Last Posted Date
2006-08-15
Lead Sponsor
Hearthstone Alzheimer Care
Target Recruit Count
20
Registration Number
NCT00197834
Locations
🇺🇸

Hearthstone at Golden Pond, Hopkinton, Massachusetts, United States

Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies

Phase 1
Terminated
Conditions
First Posted Date
2005-09-19
Last Posted Date
2006-09-14
Lead Sponsor
Weill Medical College of Cornell University
Registration Number
NCT00195156
Locations
🇺🇸

Weill Medical College of Cornell University, New York, New York, United States

Valproate in Late Life Schizophrenia

Phase 4
Completed
Conditions
Interventions
First Posted Date
2005-09-19
Last Posted Date
2015-01-06
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
20
Registration Number
NCT00194025
Locations
🇺🇸

University Hospitals of Cleveland, Cleveland, Ohio, United States

Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma

Phase 1
Withdrawn
Conditions
First Posted Date
2005-09-16
Last Posted Date
2020-05-18
Lead Sponsor
Johns Hopkins University
Registration Number
NCT00181220
Locations
🇸🇬

Johns Hopkin Singapore International Medical Center, Singapore, Singapore

Differentiation Induction in Acute Myelogenous Leukemia

First Posted Date
2005-09-15
Last Posted Date
2015-06-24
Lead Sponsor
University of Bergen
Target Recruit Count
24
Registration Number
NCT00175812
Locations
🇳🇴

Haukeland University Hospital, University of Bergen, Bergen, Norway

Determining Metabolic Effects of Valproate and Antipsychotic Therapy

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2005-09-14
Last Posted Date
2020-02-10
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
164
Registration Number
NCT00167934
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Study of Efficacy of Sodium Valproate in Therapy of Bronchial Asthma

Phase 4
Completed
Conditions
First Posted Date
2005-09-12
Last Posted Date
2009-02-19
Lead Sponsor
Centre of Chinese Medicine, Georgia
Target Recruit Count
46
Registration Number
NCT00153270

Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients

First Posted Date
2005-08-31
Last Posted Date
2013-01-28
Lead Sponsor
AstraZeneca
Target Recruit Count
17
Registration Number
NCT00139074
Locations
🇩🇰

Research Site, Kolding, Denmark

🇩🇰

Researcg Site, Svendborg, Denmark

Hormone Profiles in Adults With Newly Diagnosed Epilepsy

Phase 4
Conditions
First Posted Date
2005-08-30
Last Posted Date
2007-10-31
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
80
Registration Number
NCT00137709
Locations
🇭🇰

Prince of Wales Hospital, Shatin, Hong Kong

🇭🇰

United Christian Hospital, Kowloon, Hong Kong

© Copyright 2024. All Rights Reserved by MedPath